ETHSX Mutual Fund

ETHSX Mutual Fund

NAV$13.32
See how much of ETHSX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
$571M
Expense Ratio
1.18%
Dividend Yield (Current)
0.54%
Holdings
42
Inception Date
Jul 26, 1985
Fund Family
Eaton Vance
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+0.83%
1 Year+12.06%
3 Year+6.40%
5 Year+3.32%
10 Year+8.67%

Asset Allocation

Stocks: 99.59%
Bonds: 0.41%
See how much of ETHSX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.12.37%
ABBVAbbvie Inc.7.20%
JNJJohnson & Johnson - Common7.10%
UNHUnitedhealth Group Incorporated5.79%
AZN:LNAstraZeneca PLC5.54%
Top 10 Concentration: 59.69%Report Date: Jul 31, 2026
Download all 42 holdings for ETHSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.54%
Latest Distribution
$1.21
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

ETHSX Mutual Fund Overview

ETHSX Mutual Fund (Eaton Vance Worldwide Health Sciences Fund Class A) is managed by Eaton Vance with $571.4M in net assets. ETHSX expense ratio is 1.18%, holding 42 positions across sectors including Health Care, Financials, Consumer Discretionary. Inception date: 1985-07-26.

ETHSX performance shows a YTD return of 0.83%. The 1-year return is 12.06% and the 5-year return is 3.32%. ETHSX dividend yield stands at 0.54%.

ETHSX top holdings include Eli Lilly & Co. (12.4%), Abbvie Inc. (7.2%), Johnson & Johnson - Common (7.1%), Unitedhealth Group Incorporated (5.8%), AstraZeneca PLC (5.5%). Go to all ETHSX holdings, ETHSX sectors, or ETHSX dividends.

ETHSX can be compared against other funds. Use ETHSX overlap to find shared positions, or ETHSX vs another fund for a side-by-side view. ETHSX alternatives are available via the screener, along with tax-loss harvesting opportunities.